IMPAQTIV Trademark

Trademark Overview

On Friday, June 14, 2019, a trademark application was filed for IMPAQTIV with the United States Patent and Trademark Office. The USPTO has given the IMPAQTIV trademark a serial number of 88473351. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 12, 2023. This trademark is owned by Johnson & Johnson. The IMPAQTIV trademark is filed in the Pharmaceutical Products category with the following description:

human pharmaceutical preparations, namely, anti-virals for treatment of HIV; vaccines
impaqtiv

General Information

Serial Number88473351
Word MarkIMPAQTIV
Filing DateFriday, June 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 12, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 17, 2020

Trademark Statements

Goods and Serviceshuman pharmaceutical preparations, namely, anti-virals for treatment of HIV; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, June 12, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 12, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 4, 2022SOU EXTENSION 5 GRANTED
Thursday, October 27, 2022SOU EXTENSION 5 FILED
Friday, November 4, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 27, 2022TEAS EXTENSION RECEIVED
Wednesday, May 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 9, 2022SOU EXTENSION 4 GRANTED
Monday, May 9, 2022SOU EXTENSION 4 FILED
Monday, May 9, 2022TEAS EXTENSION RECEIVED
Thursday, October 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 26, 2021SOU EXTENSION 3 GRANTED
Tuesday, October 26, 2021SOU EXTENSION 3 FILED
Tuesday, October 26, 2021TEAS EXTENSION RECEIVED
Wednesday, March 31, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 29, 2021SOU EXTENSION 2 GRANTED
Monday, March 29, 2021SOU EXTENSION 2 FILED
Monday, March 29, 2021TEAS EXTENSION RECEIVED
Thursday, October 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 27, 2020SOU EXTENSION 1 GRANTED
Tuesday, October 27, 2020SOU EXTENSION 1 FILED
Tuesday, October 27, 2020TEAS EXTENSION RECEIVED
Tuesday, May 12, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, February 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 7, 2020SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, January 31, 2020ASSIGNED TO LIE
Monday, July 15, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 15, 2019LETTER OF SUSPENSION E-MAILED
Monday, July 15, 2019SUSPENSION LETTER WRITTEN
Thursday, July 11, 2019ASSIGNED TO EXAMINER
Wednesday, June 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 18, 2019NEW APPLICATION ENTERED

Related Keywords

impaqtiv virals treatment vaccines anti namely pharmaceutical preparations human